TY  - JOUR

T1  - Disruption of oncogenic pathways in mucoepidermoid carcinoma: CREB inhibitor 666.15 as a potential therapeutic agent

JO  - Oral Oncology

UR  - http://dx.doi.org/10.1016/j.oraloncology.2024.107029

PY  - 2024/09/26

AU  - Pérez-de-Oliveira ME

AU  - Wagner VP

AU  - Bingle CD

AU  - Vargas PA

AU  - Bingle L

ED  - 

DO  - DOI: 10.1016/j.oraloncology.2024.107029

PB  - Elsevier BV

VL  - 159

SP  - 107029

EP  - 107029

Y2  - 2024/12/22

ER  -